Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects

Pharmacology, Toxicology and Pharmaceutical Science

• Autoimmune Disease 100%
• Epitope 33%
• Fragment Antigen-Binding 66%
• Immunogenicity 33%
• Malignant Neoplasm 33%
• Single Chain Fragment Variable Antibody 33%

Immunology and Microbiology

• Autoimmune Disease 100%
• Epitope 33%
• Fragment Antigen-Binding 66%
• Immunogenicity 33%
• Single-Chain Variable Fragment 33%
• Solution and Solubility 33%

Biochemistry, Genetics and Molecular Biology

• Autoimmunity 100%
• Fragment Antigen-Binding 66%
• Immunogenicity 33%
• Single-Chain Variable Fragment 33%
• Solution and Solubility 33%